Skip to content

Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease

Frailty Trajectories and Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease: A Longitudinal Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06065501
Enrollment
120
Registered
2023-10-04
Start date
2023-10-19
Completion date
2024-09-30
Last updated
2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD - Chronic Kidney Disease

Brief summary

This is a randomized controlled trial study conducted on frail patients with chronic kidney disease(CKD).

Detailed description

The study will be conducted on 120 frail patients with CKD, who will be divided into 2 groups: Group 1, consisting of 60 frail patients, will receive PACE intervention (based on mobile social network support) for 6 months. Group 2, comprising 60 frail patients, will receive usual CKD education and consultation for 6 months.

Interventions

BEHAVIORALPACE intervention

The PACE intervention involves using Line (technological devices) to establish a collaborative group with patients. The researchers will regularly provide reminders to chronic kidney disease patients regarding the importance of nutrition and exercise. They will also provide information on how to adhere to nutritional and exercise regimens, offering praise for consistent performance.

BEHAVIORALUsual care

Nurses provide routine education and consultation

Sponsors

National Cheng Kung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with CKD stage 1 to 5 * Participants with pre-frail and frail conditions. * Having access to a mobile phone and is capable of using mobile social network application (Line)

Exclusion criteria

* Received renal replacement therapy * Participants achieved TTM stage 5

Design outcomes

Primary

MeasureTime frameDescription
Tilburg Frailty Indicator (TFI)Baseline, 3 months, and 6 months post-interventionFrailty was measured using the Tilburg Frailty Indicator (TFI), a 15-item self-reported questionnaire assessing physical, psychological, and social domains. Total score ranges from 0 to 15, with higher scores indicating greater frailty.

Secondary

MeasureTime frameDescription
Physical Activity Level Measured by IPAQ-TaiwanBaseline, 3 months, and 6 months post-interventionPhysical activity was assessed using the International Physical Activity Questionnaire - Taiwan version (IPAQ-Taiwan). Total physical activity score was calculated in MET-minutes/week, including walking, moderate, and vigorous intensity activities.
Health-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)Baseline, 3 months, and 6 months post-interventionLifestyle behaviors were assessed using the HPLP-II, Taiwan version, including six subscales. Scores range from 52 to 208, with higher scores indicating more frequent health-promoting behaviors.
Nutritional Status Measured by MNA-SFBaseline, 3 months, and 6 months post-interventionNutritional status was assessed using the Mini Nutritional Assessment - Short Form (MNA-SF), a 6-item tool scored 0-14. Higher scores indicate better nutritional status. A score ≥12 is considered normal. The Taiwan version was used.

Countries

Taiwan

Participant flow

Recruitment details

Patients with CKD were recruited from outpatient clinics in hospitals located in southern Taiwan. The eligibility criteria included: (i) age 20 years or older; (ii) diagnosis of CKD stage 1 to 5 for at least 6 months; (iii) identified as frail; (iv) the ability to communicate in Mandarin Chinese or Taiwanese; and (v) willingness to participate in the study. The exclusion criteria were: (i) receiving renal replacement therapy, (ii) a history of mental illness, and (iii) having reached TTM stage 5

Pre-assignment details

A total of 120 participants were enrolled and assigned to study arms.

Participants by arm

ArmCount
PACE Intervention
The intervention group (PACE intervention) utilizes mobile social network support, employing a LINE group to implement a personalized plan based on the TTM model for establishing a care program.
60
Control Group
The control group receives usual care, which involves standard CKD education and consultation.
60
Total120

Baseline characteristics

CharacteristicPACE InterventionControl GroupTotal
Age, Continuous66.70 Years
STANDARD_DEVIATION 13.25
69.10 Years
STANDARD_DEVIATION 11.65
67.90 Years
STANDARD_DEVIATION 12.48
Body Mass Index (BMI)25.73 kg/m²
STANDARD_DEVIATION 5.85
26.14 kg/m²
STANDARD_DEVIATION 4.74
25.93 kg/m²
STANDARD_DEVIATION 5.31
Education Level
High school or college
27 Participants23 Participants50 Participants
Education Level
Middle school or below
22 Participants30 Participants52 Participants
Education Level
University or above
11 Participants7 Participants18 Participants
Estimated Glomerular Filtration Rate (eGFR)36.00 mL/min/1.73m²
STANDARD_DEVIATION 23.63
39.92 mL/min/1.73m²
STANDARD_DEVIATION 20.34
37.96 mL/min/1.73m²
STANDARD_DEVIATION 22.94
Hand Grip Strength23.93 kg
STANDARD_DEVIATION 9.76
23.31 kg
STANDARD_DEVIATION 10.82
23.62 kg
STANDARD_DEVIATION 10.27
Living Status
lived alone
11 Participants9 Participants20 Participants
Living Status
living with family
49 Participants51 Participants100 Participants
Marital Status
married
40 Participants35 Participants75 Participants
Marital Status
single
10 Participants9 Participants19 Participants
Marital Status
widowed
10 Participants16 Participants26 Participants
Race and Ethnicity Not Collected0 Participants
Serum Albumin4.30 g/dL
STANDARD_DEVIATION 0.53
4.28 g/dL
STANDARD_DEVIATION 0.38
4.29 g/dL
STANDARD_DEVIATION 0.46
Sex: Female, Male
Female
27 Participants30 Participants57 Participants
Sex: Female, Male
Male
33 Participants30 Participants63 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 600 / 60
other
Total, other adverse events
0 / 600 / 60
serious
Total, serious adverse events
1 / 600 / 60

Outcome results

Primary

Tilburg Frailty Indicator (TFI)

Frailty was measured using the Tilburg Frailty Indicator (TFI), a 15-item self-reported questionnaire assessing physical, psychological, and social domains. Total score ranges from 0 to 15, with higher scores indicating greater frailty.

Time frame: Baseline, 3 months, and 6 months post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
PACE InterventionTilburg Frailty Indicator (TFI)Baseline5.38 score on a scaleStandard Deviation 2.62
PACE InterventionTilburg Frailty Indicator (TFI)3 months post-intervention4.16 score on a scaleStandard Deviation 2.69
PACE InterventionTilburg Frailty Indicator (TFI)6 months post-intervention4.43 score on a scaleStandard Deviation 2.81
Control GroupTilburg Frailty Indicator (TFI)Baseline4.97 score on a scaleStandard Deviation 2.96
Control GroupTilburg Frailty Indicator (TFI)3 months post-intervention4.16 score on a scaleStandard Deviation 2.37
Control GroupTilburg Frailty Indicator (TFI)6 months post-intervention4.74 score on a scaleStandard Deviation 2.56
Secondary

Health-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)

Lifestyle behaviors were assessed using the HPLP-II, Taiwan version, including six subscales. Scores range from 52 to 208, with higher scores indicating more frequent health-promoting behaviors.

Time frame: Baseline, 3 months, and 6 months post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
PACE InterventionHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)Baseline149 scores on a scaleStandard Deviation 19.93
PACE InterventionHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)3 months post-intervention152.93 scores on a scaleStandard Deviation 19.71
PACE InterventionHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)6 months post-intervention149.81 scores on a scaleStandard Deviation 24.35
Control GroupHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)Baseline144.6 scores on a scaleStandard Deviation 21.23
Control GroupHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)3 months post-intervention149.60 scores on a scaleStandard Deviation 20.21
Control GroupHealth-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)6 months post-intervention142.46 scores on a scaleStandard Deviation 25.72
Secondary

Nutritional Status Measured by MNA-SF

Nutritional status was assessed using the Mini Nutritional Assessment - Short Form (MNA-SF), a 6-item tool scored 0-14. Higher scores indicate better nutritional status. A score ≥12 is considered normal. The Taiwan version was used.

Time frame: Baseline, 3 months, and 6 months post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
PACE InterventionNutritional Status Measured by MNA-SFBaseline12.25 score on a scaleStandard Deviation 1.76
PACE InterventionNutritional Status Measured by MNA-SF3 months post-intervention12.49 score on a scaleStandard Deviation 1.3
PACE InterventionNutritional Status Measured by MNA-SF6 months post-intervention12.42 score on a scaleStandard Deviation 1.58
Control GroupNutritional Status Measured by MNA-SFBaseline12.55 score on a scaleStandard Deviation 1.6
Control GroupNutritional Status Measured by MNA-SF3 months post-intervention12.59 score on a scaleStandard Deviation 1.61
Control GroupNutritional Status Measured by MNA-SF6 months post-intervention12.35 score on a scaleStandard Deviation 1.86
Secondary

Physical Activity Level Measured by IPAQ-Taiwan

Physical activity was assessed using the International Physical Activity Questionnaire - Taiwan version (IPAQ-Taiwan). Total physical activity score was calculated in MET-minutes/week, including walking, moderate, and vigorous intensity activities.

Time frame: Baseline, 3 months, and 6 months post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
PACE InterventionPhysical Activity Level Measured by IPAQ-TaiwanBaseline3650.88 MET-minutes/weekStandard Deviation 2057.09
PACE InterventionPhysical Activity Level Measured by IPAQ-Taiwan3 months post-intervention3248.18 MET-minutes/weekStandard Deviation 1950.36
PACE InterventionPhysical Activity Level Measured by IPAQ-Taiwan6 months post-intervention3588.53 MET-minutes/weekStandard Deviation 2117.56
Control GroupPhysical Activity Level Measured by IPAQ-TaiwanBaseline3971.91 MET-minutes/weekStandard Deviation 3647.7
Control GroupPhysical Activity Level Measured by IPAQ-Taiwan3 months post-intervention3891.37 MET-minutes/weekStandard Deviation 2747.92
Control GroupPhysical Activity Level Measured by IPAQ-Taiwan6 months post-intervention3259.35 MET-minutes/weekStandard Deviation 2140.04

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026